【摘 要】
：
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies,a series of novel DAPY derivatives were rationally designed,synthesized and evaluated for their anti-HIV activities
【机 构】
：
Department of Medicinal Chemistry,Key laboratory of Chemical Biology(Ministry of Education),School o
【出 处】
：
全国药物化学学术会议暨第四届中英药物化学学术会议
论文部分内容阅读
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies,a series of novel DAPY derivatives were rationally designed,synthesized and evaluated for their anti-HIV activities.
其他文献
吡咯[1,2-f][1,2,4]三嗪类结构化合物在药物化学领域中表现出抗肿瘤、抗炎症活性,比如EGFR 酪氨酸激酶抑制剂BMS690514 、BMS599626 及IGFR1R 抑制剂 BMS754807 等都含有此类结构,因此对其合成研究正受到广泛地关注。含异喹啉类结构的化合物在天然产物及上市药物中也经常出现。我们课题组在前期研究工作的基础上,设计一类铜催化的偶联环化反应合成吡咯[1,2-f][
Podophyllotoxin(PPT)has cathartic,antiviral and antimitotic activity.1,2 As part of our ongoing efforts towards the development of new podophyllotoxin-based compounds with potent activities3,we synthe
Lycogarubin C 是由Steglich 和 Akazawa 在1994 年分别独立的从粘细菌Lycogala epidendrum 中分离得到的海洋天然产物.Lycogarubin C 有一定的抗肿瘤活性,以其他取代的芳基代替Lycogarubin C 中的吲哚环,设计合成了一系列的Lycogarubin C 类似物.它们的合成以亚氨基二乙酸为起始原料,经过成酯、保护、环合、磺酰化、su
他汀类降血脂药物是一种3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂,可阻断HMG-CoA 转变为胆固醇前体甲羟戊酸,并反馈性激活肝脏低密度脂蛋白受体(LDLR),使肝脏胆固醇合成受阻,引起细胞内胆固醇减少,从而显著降低血清总胆固醇(TC)及低密度脂蛋白胆固醇浓度[1].现有的他汀类药物(如：洛伐他丁、辛伐他汀、氟伐他汀、阿托伐他汀、罗素伐他汀等)分子结构中都包含有(3R,5R)-二
A number of research groups have attempted to determine the absolute configuration of(+)-mefloquine hydrochloride since 1974.Very surprisingly,its absolute configuration is controversial for nearly 40
合成系列新的查尔酮衍生物,对其抑制beta-Amyloid(Aβ)聚集的活性进行研究,大部分化合物的抑制活性都比母体化合物好.其中分子式为C21H21NO5 的化合物4d(图1)具有很好的抑制Aβ(1-42)自聚集的活性,IC50 = 2.2 ± 1.5μM[1].为了研究化合物抑制Aβ 聚集的机制,我们利用计算机辅助进行分子对接和分子动力学研究,对化合物的结合模式和结合能量以及Ab蛋白23～28
We have recently prepared O-and S-glycosyl aryl boronic acids,which are proved as viable material for further applications.We demonstrate hereby that these compounds are useful in organic synthesis an
A series of new isoliquiritigenin(ISL)derivatives were synthesized and evaluated as inhibitors for amyloid-beta(Aβ)aggregation.It was found that all these synthetic compounds inhibited Aβ(1-42)self-ag
G-四链体是新型抗肿瘤药物的有效作用靶点之一.至今已开发的G-四链体配体分子多以π-π堆积的方式作用于末端G-四集体上,但由于同样对双链DNA有一定的亲和力而带来副作用.一些氨基糖类可以特异性识别G-四链体的沟区和(或)loop.基于此,我们设计了一类新型的G-四链体配体分子,采用柔性连接策略,将经典的平面型核酸嵌入剂分子(如吖啶类的原黄素,Proflavine),通过不同长度的连接臂,与不同大小
NM23-H2 protein is identified as a transcriptional factor of the important oncogene c-myc,that can bind specifically to defined DNA sequences to promote gene transcription.However,due to its role in t